Dry Eye

A new therapy is being investigated in a phase IIb trial to test its safety and effectiveness in patients with moderate-to-severe dry eye disease.

In our latest episode, Laura M. Periman, MD, shares her experience using intense pulsed light (IPL) therapy, and the benefits she's found in it for treating patients with chalazion.

Supplementation no better than placebo as results confirm previous research

A common symptom, dry eye can have an adverse impact on visual recovery and outcomes

New compounds could offer more options for physicians in treating patients, leading to better outcomes. 

Diagnostic tools allow clinicians opportunity to assess underlying cause and diagnose dry eye earlier

Study offering physicians new and innovative ways to approach DED

Harvey A. Fishman, MD, PhD, shares why intense pulsed light (IPL) therapy is a valuable asset in any ophthalmologist's toolbox

Poor eyelid performance while sleeping a common contributing factor

Centuries of research show treating deficiencies can have dramatic impact

The industry is increasing awareness during Dry Eye Awareness Month in July. 

Manufacturers’ global revenues for dry eye treatments is expected to top $6 billion in 2023.

Here's why John Sheppard, MD, believes nutrition should be the cornerstone of dry eye therapy.

When used in supplement with other dry eye treatments, patients see improvement

Topical drug for the treatment of dry eye disease sees potential 

Laura M. Periman, MD, shares how IPL therapy can quickly rid patients of painful chalazions

Stephen C. Pflugfelder, MD, honored as the recipient of the Binkhorst Lecture and medal at ASCRS 2019, lectured on the quest for tear stability in dry eye patients.